NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-211 Cr | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-211 Cr |
| Mar2024 | ₹-247 Cr |
| Mar2023 | ₹-363 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹-186 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-211 Cr | Negative | |
| Mar2024 | ₹-247 Cr | Negative | |
| Mar2023 | ₹-363 Cr | Negative | |
| Mar2022 | ₹35 Cr | Positive | |
| Mar2021 | ₹-186 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,806.5 Cr | 4.2% | 2.6% | -35.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 4.2% |
2.6% |
-35.8% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses